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ABSTRACT
Haploid embryonic stem cells (ESCs) are useful for studying mammalian genes
because disruption of only one allele can cause loss-of-function phenotypes. Here,
wereporttheuseofhaploidESCsandtheCRISPRRNA-guidedCas9nucleasegene-
targeting system to manipulate mammalian genes. Co-transfection of haploid ESCs
with vectors expressing Cas9 nuclease and single-guide RNAs (sgRNAs) targeting
Tet1,Tet2,andTet3resultedinthecompletedisruptionofallthreegenesandcauseda
loss-of-functionphenotypewithhigheYciency(50%).Co-transfectionofcellswith
vectors expressing Cas9 and sgRNAs targeting two loci on the same chromosome
resulted in the creation of a large chromosomal deletion and a large inversion. Thus,
theuseoftheCRISPRsystemincombinationwithhaploidESCsprovidesapowerful
platformtomanipulatethemammaliangenome.
Subjects Developmental Biology, Genetics
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INTRODUCTION
Generation of homozygous mutant mammalian cells is complicated because they
have a diploid genome. If one allele of an autosomal gene is disrupted, the resulting
heterozygous mutant may not display a phenotype due to the existence of the other
allele; therefore, studying the functions of genes in mammalian cells can be challenging.
The “complication” of ES cell diploidy for genetic analysis has been addressed either
by selecting “targeted” clones undergoing LOH (facilitated by mutagenesis using a
hypomorphic neor gene) or by sequential targeting both chromosomes using diVerent
resistance genes (Mortensen et al., 1991; Milstone, Bradwin & Mortensen, 1999). Haploid
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system. PeerJ1:e230; DOI10.7717/peerj.230cells contain only one copy of each chromosome and disruption of one allele can directly
cause loss-of-function phenotypes. Recently, mouse haploid embryonic stem cells (ESCs)
have been successfully generated, providing an ideal tool for genetic analyses (Elling et
al., 2011; Leeb & Wutz, 2011). Haploid ESCs retain the majority of the biological aspects
of normal diploid ESCs, except for their unusual karyotype. A genome-wide expression
analysis revealed that the expression proﬁles of haploid and diploid ESCs, including
stem cell markers, are almost identical (Leeb & Wutz, 2011). Haploid ESCs are able to
diVerentiateintoawiderangeofcelltypesbothin vitroandinchimericembryosproduced
by blastocyst injection. During diVerentiation, the cells gain a diploid karyotype (Leeb &
Wutz, 2011). Remarkably, haploid ESCs are germline competent in chimeric mice (Leeb et
al.,2012;Lietal.,2012;Yangetal.,2012).
The recent development of site-speciﬁc endonucleases for selective genome cleavage
has been an important advancement in mammalian genome engineering. These enzymes
includezinc-ﬁngernucleases(Porteus&Carroll,2005),transcriptionactivator-likeeVector
nucleases (Miller et al., 2011), and clustered regularly interspaced short palindromic
repeats (CRISPR) RNA-guided Cas9 nucleases (Cong et al., 2013; Mali et al., 2013).
Zinc-ﬁnger nucleases and transcription activator-like eVector nucleases are composed of
programmable, sequence-speciﬁc DNA-binding modules linked to a non-speciﬁc DNA
cleavage domain. CRISPR RNA-guided Cas9 nucleases use small base-pairing RNAs
to target and cleave foreign DNA elements in a sequence-speciﬁc manner (Wiedenheft,
Sternberg & Doudna, 2012). Among these technologies, the type II CRISPR system from
Streptococcus pyogenes is the simplest. In this system, a single gene encoding the Cas9
protein and two RNAs, a mature CRISPR RNA (crRNA) and a partially complementary
trans-acting RNA (tracrRNA), are suYcient for RNA-guided cleavage of foreign DNAs
(Jinek et al., 2012). Maturation of crRNA requires RNase III and tracrRNA (Deltcheva et
al., 2011); however, this process can be bypassed by using an engineered small guide RNA
(sgRNA) containing a hairpin that mimics the tracrRNA-crRNA complex and a short
sequence complementary to the target DNA (Jinek et al., 2012). The Cas9 endonuclease
can generate sequence-speciﬁc double-strand breaks of target DNAs bound to sgRNAs.
The binding site of a target DNA requires a protospacer-adjacent motif (PAM) (with the
sequence NGG) juxtaposed to the DNA complementary region (MarraYni & Sontheimer,
2010). Therefore, the CRISPR RNA-guided Cas9 nuclease system requires only two
molecules:theCas9proteinandasgRNAforhost-independentgene-targeting.
Here, we describe a new platform for simple genetic manipulation of the mammalian
genome that uses a combination of the CRISPR RNA-guided Cas9 nuclease system and
haploidESCs.
MATERIALS AND METHODS
Parthenogenetic activation
Oocytes were collected from superovulated B6DBAF1 and B6-EGFP females and were
activated in calcium free M16 medium containing 5 mM strontium chloride. After
activation for 3 h, the embryos were subsequently cultured in M16 medium. All animal
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GunmaUniversity,ShowaCampus,Japan.
Generation of haploid ES cell lines
ESC derivation was performed as described previously with minor modiﬁcations (Leeb &
Wutz, 2011; Horii et al., 2008). Brieﬂy, the zonas of morula stage embryos were removed
andthenculturedinchemicallydeﬁnedESmediumsupplementedwith3MCHIR99021
and1MPD0325901(2i).
Fluorescence-activated cell sorting (FACS) analysis
The cells were stained with 15 g/ml Hoechst 33342 (Invitrogen) and then cell sorting for
DNA content was performed using a FACS Aria III cell sorter (Becton Dickinson). The
haploid 1n peak was puriﬁed. The cells were ﬁxed in 70% ethanol, digested with RNase
and stained with propidium iodide, and then analytic ﬂow proﬁles of DNA content were
recordedusingaFACSCaliburﬂowcytometer(BectonDickinson).
Transfection of cells
ThegeneratedhaploidEScelllineswereculturedongelatine-coatedplatesunderstandard
ESC culture conditions. Before transfection ESCs were sorted and haploid fractions were
collected (Fig. S1). The cells were co-transfected with a plasmid expressing mammalian
codon-optimized Cas9 under the control of a CAG promoter and plasmids expressing
sgRNAs under the control of a U6 promoter (Horii et al., 2013), along with a linear
puromycin marker (Clontech). Transfections were performed using Lipofectamine 2000
reagent (Life Technologies) according to the manufacturer’s instructions. In the triple
targeting experiments, cells were co-transfected with a plasmid expressing mammalian
codon-optimized Cas9 and three plasmids expressing sgRNAs targeting Tet1, Tet2 and
Tet3, along with a linear puromycin marker (Clontech). Twelve hours after transfection,
ESCs were replated at a low density. One day after replating, cells were incubated with
1 g/ml puromycin for 48 h. After recovering for 4 to 6 days, individual colonies were
picked and genotyped by PCR-RFLP, or passaged several times and frozen. Full details of
thetargetedsequencesandprimersareshowninTableS2.
Assay for genome modiﬁcation
To detect small genome modiﬁcations, PCRs were performed using primers ﬂanking
the targeted regions (Table S2). The PCR products were digested with BfuAI or MnII,
which cleave at the Cas9 target site of non-modiﬁed genomes, and then analysed by to
gel electrophoresis. To detect large deletions and inversions, PCRs were performed using
primers ﬂanking the target sites of the two Tet1-speciﬁc sgRNAs (Table S2, Figs. 4A and
4B). A deletion was indicated by the production of a 300 bp product. An inversion
was indicated by the production of 190 bp and 260 bp products. All of the mutant
PCR products were cloned into a TA-cloning vector (pCR2.1) and the mutations were
conﬁrmedbyDNAsequencing.
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content
Thedeterminationofthe5hmClevelsinDNAfromtriple-targetedhaploidESCcloneswas
performed as described previously with slight modiﬁcations (Szwagierczak et al., 2010).
Brieﬂy, 200 ng of genomic DNA was incubated with 10 pmol of -GT and 1.91 kBq of
[3H]-UDP-glucose (Perkin Elmer) at 25C in a 25 l reaction buVer comprising 50 mM
potassium acetate, 10 mM magnesium acetate, 1 mM DTT and 20 mM Tris-acetate (pH
7.9). After 1 h, the mixture was added to 20 g of proteinase K in 1% (w/v) SDS and then
incubated at 55C for 30 min. After the incubation, the reaction mixture was spotted
onto a DE81 ﬁlter disc (GE Healthcare). The disc was washed as described previously
(Suetakeetal.,2003),andtheincorporatedradioactivitywasdeterminedusinganLS-5000
scintillationcounter(Beckman).
Quantiﬁcation of the 5hmC content of Ecat1
The 5hmC content of the Ecat1 gene was measured using the Quest 5-hmC Detection
Kit (Zymo Research, Irvine). This kit enables sequence-speciﬁc detection of 5hmC
within DNA; utilizing a 5hmC glucosyltransferase, 5hmC in DNA is speciﬁcally tagged
with a glucose moiety yielding the modiﬁed base glucosyl-5hmC. After glucosylation
of 5hmC, the DNA was digested with a glucosyl-5hmC-sensitive restriction endonu-
clease (MspI) and then quantitative PCR was performed using Ecat1-speciﬁc primers:
50-GGAGAGCACATCCCACATCT-30 and50-GTGAGCCAGATCAGTGAGCA-30.
RESULTS
Generation of haploid ESCs from mouse embryos
To generate haploid mouse embryos, unfertilized oocytes isolated from superovulated
B6DBAF1hybridfemalemiceandB6-EGFPmicewereactivatedusingstrontiumchloride
inthecalciumfreeM16medium.AftercultureinM16medium,26morulaewereobtained
from 58 activated B6DBAF1 oocytes and were used for generation of ESCs (Table S1).
Inner cell masses were cultured in chemically deﬁned dual inhibition (2i) ES medium
supplemented with 3 M CHIR99021 and 1 M PD0325901 to inhibit glycogen synthase
kinase 3 and mitogen-activated protein kinase, respectively. A total of 17 B6DBAF1 ESC
lines were obtained, of which 82% had haploid DNA content (Table S1). Similar results
were also obtained for B6-EGFP mice (Table S1); in this inbred strain, 70% of the 10 ESC
linesobtainedhadhaploidDNAcontent.
Targeting single genes in haploid ESCs
Becausehaploidcellshaveonlyonecopyofeachchromosome,disruptionofoneallelecan
directly cause a loss-of-function phenotype. To examine the eYciency of loss-of-function
haploidESCs,sgRNAsweredesignedtotargettheTet1,Tet2andTet3genes,whichencode
members of the tet methylcytosine dioxygenase family (Fig. 1A). Tet proteins convert
5-methylcytosine to 5-hydroxymethylcytosine (5hmC) and this process is an important
part of DNA demethylation (Tahiliani et al., 2009). A previous study of the speciﬁcity of
typeIICRISPRsuggestedthattheDNAtargetsitemustperfectlymatchthePAMsequence
Horii et al. (2013), PeerJ, DOI 10.7717/peerj.230 4/14Figure 1 Identiﬁcation and sequencing of successfully targeted Tet1, Tet2, and Tet3 genes in mouse
haploid ESCs. (A) The Cas9/sgRNA-targeting sites in mouse Tet1, Tet2 and Tet3. The sgRNA-targeting
sequences are underlined and the PAM sequences are indicated in red. Exons are indicated by closed
boxes and the open boxed areas indicate the restriction sites in each target region. (B) Identiﬁcation of
successfully targeted Tet1, Tet2, and Tet3 genes in mouse haploid ESCs. (continued on next page...)
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PCR products were digested with restriction enzymes (BfuAI or MnII) that cleave at the Cas9 endonucle-
ase target sites and then analysed by gel electrophoresis. PCR products generated from clones containing
successfully targeted Tet1, Tet2 and Tet3 genes were uncleaved and were larger than the product generated
fromthewild-type(WT)clone.Theclonenumbersareshownabovethegelimages.Theasterisksindicate
successfullytargetedclones.(C)SequencingofthesuccessfullytargetedTet1,Tet2andTet3mutantclones.
The PAM sequences are shown in red and the boxed areas indicate the restriction sites in the target
regions. Lower case letters indicate insertion mutations and arrows indicate the sites of insertions.
(NGG) and the 12 bp seed sequence at the 30 end of the sgRNA (Jinek et al., 2012). The
importanceoftheremainingbasesislesswellunderstoodandmaydependonthebinding
strength of the matching sgRNA or the inherent tolerance of Cas9 itself. Therefore, we
selecteda23-mersequence(N21GG)fromthetargetgeneandused16bpofthissequence
(N14GG) to search for homologous mouse genes. Sequences that did not cross-react with
any other sites in the mouse genome were selected and were used to construct the sgRNA
expression vectors. To obtain high expression levels of Cas9 in ESCs, the expression vector
wasengineeredtocontainmammaliancodon-optimizedCas9underthecontrolofaCAG
promoter (Mali et al., 2013). To examine the eYciency of knockout of each gene, haploid
ESCs were co-transfected with the Cas9 expression vector and a sgRNA vector targeting
Tet1, Tet2 orTet3, along with a puromycin marker. Transfected cells were treated with
1 g/ml puromycin for 48 h. Each targeted locus contains a restriction site; therefore, the
cleavageeYcienciesoftheTet1,Tet2andTet3genesweredeterminedbydigestingthePCR
products with BfuAI (Tet1 and Tet3) or MnII (Tet2) (Fig. 1A). Successful targeting was
indicatedbyadisruptionoftherestrictionsite;successfullytargetedalleleswereuncleaved
and wild-type alleles underwent complete cleavage. A total of 20 haploid ESC clones from
each targeting experiment were screened; the percentages of clones that were successfully
targeted were 20%, 30% and 65% for Tet1, Tet2 and Tet3, respectively (Fig. 1B). The PCR
productsofthesuccessfullytargetedregionsweresubclonedandsequenced(Fig.1C).The
resultsconﬁrmedthateachclonecontainedamutationinthespeciﬁcTet geneattheBfuAI
orMnIIrestrictionsite.
Simultaneous disruption of the Tet1, Tet2 and Tet3 genes
Higher organisms usually have redundant genes and in these cases it is important to
disrupt all members of the gene family simultaneously. Therefore, experiments were
performed to determine whether the Tet1, Tet2 and Tet3 genes could be simultaneously
targeted.HaploidESCswereco-transfectedwiththeCas9expressionvectorandthesgRNA
vectors targeting Tet1, Tet2 and Tet3, along with a puromycin marker. Transfected cells
were treated with 1 g/ml puromycin for 48 h. Of the 20 haploid ESC clones screened,
2 (10%) were identiﬁed as complete triple knockout clones. Sequencing of the subcloned
PCR products conﬁrmed that the two triple knockout clones did contain mutations
in the Tet1, Tet2 and Tet3 alleles (Fig. 2A). To determine whether the triple knockout
mutants had lost methylcytosine dioxygenase activity, the 5hmC content of the targeted
clones was compared to that of wild-type haploid ESCs. Both the global 5hmC content
(Fig. 2B) and the 5hmC content of the Ecat1 gene (Fig. 2C) were markedly lower in the
Horii et al. (2013), PeerJ, DOI 10.7717/peerj.230 6/14Figure2 SimultaneoustargetingoftheTet1,Tet2andTet3genesinmousehaploidESCs.(A)Sequenc-
ing of Tet1, Tet2 and Tet3 triple knockout mutant clones. The PAM sequences are shown in red and
the boxed areas indicate the restriction sites in the target regions. Lower case letters indicate insertion
mutations and arrows indicate the sites of insertions. (B, C) Quantiﬁcation of the 5hmC content in triple
knockout clones. Analysis of the global 5hmC levels (B) and the 5hmC (continued on next page...)
Horii et al. (2013), PeerJ, DOI 10.7717/peerj.230 7/14Figure2(...continued)
levels in the Ecat1 gene (C) in DNA from two triple knockout (TKO) haploid ESC clones. The quantiﬁ-
cation of genomic 5hmC was based on the speciﬁc transfer of radiolabeled glucose to 5hmC by a puriﬁed
glucosyltransferase. Data are represented as the mean C SD of n D 3 replicate measurements and are
shown as a percentage of the 5hmC levels in the wild type (WT). (D) Sequencing of Tet1, Tet2, and Tet3
tripleknockoutmutantcloneswasobtainedfollowingtreatmentwithahighconcentrationofpuromycin.
PAM sequences are shown in red and the boxed areas indicate the restriction sites of the target regions.
Lower case letters indicate insertion mutations and arrows indicate the sites of insertions.
two clones carrying triple mutations than in a wild-type clone. To enhance the eYciency
with which triple knockout clones were generated, the concentration of puromycin that
cells were treated with was increased to 2 g/ml. This markedly increased the eYciency
with which triple knockout clones were generated to 50%. Of the 20 haploid ESC clones
screened, 10 were identiﬁed as triple knockout clones (Fig. 2D). Further analysis of two
triple knockout ESCs reveals that these cells were become diploid after several passages
(Fig. S2). Expression level of pluripotent marker genes (Oct3/4 and Nanog) are not
diVerent between triple knockout ESCs and wild type ESCs. However, diVerentiation
markers, such as Cdx2 (trophectoderm) and Brachyury (mesoderm) were upregulated,
whereas Gata6 (primitive endoderm) were downregulated in triple knockout ESCs
(Fig. S3). In addition, these triple knockout ESCs grow more slowly than wild type ESCs
(Fig.S4).
Chromosomal deletions and inversions can be induced by
Cas9/RNA-mediated genomic engineering
Structuralmodiﬁcationsintheformofchromosomaldeletionsandvariablecopynumbers
account for a signiﬁcant portion of human genetic variation (Feuk, Carson & Scherer,
2006). Therefore, we investigated whether the simultaneous delivery of two sgRNAs
targeting the same chromosome could induce large chromosomal deletions or inversions.
Two sgRNAs targeting exon 4 and exon 7 of Tet1 were used; the distance between the
two target sites was 14 kb (Fig. 3A). PCR primers ﬂanking the target regions were used
to determine whether the sgRNAs had successfully targeted the DNA. Deletion of the
14 kb sequence was indicated by the generation of a PCR product of approximately
300 bp. A large population (30%) of the 20 transfectant ESCs screened produced the
300 bp PCR product indicative of a deletion event (Fig. 3B). Sequencing of these PCR
productsconﬁrmedlargedeletionsaccompaniedbythedeletionofveryfewnucleotidesat
their junctions (Fig. 3C). These results indicate that co-transfection of ESCs with vectors
expressing Cas9 and sgRNAs targeting exons 4 and 7 of Tet1 creates a large chromosomal
deletion(14kb)withhigheYciency.
The possibility that the two sgRNAs targeting exon 4 and exon 7 of Tet1 could create
inversionswasthenexaminedbyPCRampliﬁcationusingprimersthatspannedthenewly
created50-and30-junctionsateachexon.Inversioneventswereindicatedbythegeneration
of 190 bp and 260 bp PCR products (Fig. 4A). Of the 20 transfectant ESCs screened,
10% underwent inversions (Fig. 4B). Sequencing of the two PCR products conﬁrmed in-
version events with the deletion of very few nucleotides at their junctions (Fig. 4C). These
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mouse haploid ESCs. (A) The two sgRNA-targeting sites in the Tet1 gene. Exons are indicated by closed
boxes, the sgRNA-targeting sequences are indicated by green arrowheads, and the PCR primers used for
detection of the deletion are indicated by red arrows. (B) Detection of deletions in the Tet1 gene in ESCs
targeted with two sgRNAs. PCRs were performed using primers ﬂanking the sgRNA target sites in exons
4 and 7, as shown in (A). A deletion event resulted in the production of a 300 bp product. The clone
numbers are shown above the gel image. Control PCR using primers amplifying the Tet1 region which is
not deleted in this experiment was also performed. (C) Sequencing of the PCR products of ESC clones
containing Tet1 deletions. The sgRNA-targeting sequences are underlined and the PAM sequences are
indicated in red.
Horii et al. (2013), PeerJ, DOI 10.7717/peerj.230 9/14Figure 4 Large chromosomal inversions mediated by two sgRNAs targeting the same chromosome
in mouse haploid ESCs. (A) The two sgRNA-targeting sites in the Tet1 gene. The sgRNA-targeting
sequences are indicated by arrowheads and the PCR primer sets ﬂanking the 50- and 30-ends of the
inversion locus are indicated by red and blue arrows. (B) Detection of inversions in the Tet1 gene in
ESCs targeted with two sgRNAs. PCRs were performed using primers ﬂanking the 50 and 30 ends of the
inversion locus. An inversion event was indicated by the production of PCR products of approximately
190 bp and 260 bp. The clone numbers are shown above the gel images. Control PCR using primers
amplifying the Tet1 region which is not deleted in this experiment was also performed. (C) Sequencing
of the PCR products of ESC clones containing Tet1 inversions. The sgRNA-targeting sequences are
underlined and the PAM sequences are indicated in red. Lower case letters indicate insertion mutations.
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DISCUSSION
Homozygous mutant mammalian cells are useful for studies of gene function; however,
the production of homozygous knockouts is time consuming and complicated because
diploid cells require disruption of two alleles. The recent development of mouse haploid
ESCs(Ellingetal.,2011;Leeb&Wutz,2011)hasprovidedanidealtoolforgeneticanalyses
because haploid cells have only one copy of each chromosome and the disruption of a
single allele can directly cause loss-of-function phenotypes. The CRISPR RNA-guided
Cas9 nuclease system is a simple and eYcient technology for gene targeting (Wiedenheft,
Sternberg & Doudna, 2012). Here, we combined the use of haploid ESCs and the
CRISPR/Cas9 system to develop a method of studying gene function. Co-transfection of
vectors expressing the Cas9 nuclease and sgRNAs targeting Tet1, Tet2 and Tet3 completely
disruptedallthreegenesandcausedloss-of-functionphenotypesathigheYciency(50%).
ThiseYciencyisremarkablyhigherthanthatreportedinarecentstudyoftripleknockout
ESCs(Wangetal.,2013).
Structural variations in the form of chromosomal deletions, inversions, and changes in
copy number account for a signiﬁcant portion of human genetic variation (Feuk, Carson
& Scherer, 2006). This study demonstrates that the Cas9/CRISPR system can be used to
generate large chromosomal deletions and inversions in mammals eYciently by a single
co-transfection of ESCs with two sgRNAs that target the same chromosome. One of the
merits of using haploid ESCs for generating deletions and inversions is that the presence
of a single chromosome precludes unintended rearrangements between homologous
chromosomes, as reported in diploid cells (Clark et al., 2007). The majority of useful
rearrangementswilllikelyoccuronautosomes;therefore,theuseofCas9/CRISPRgenome
engineering of haploid ESCs would be of great merit to applications that extend beyond
the modelling of human disease. The generation of large chromosomal deletions could
be useful for functional analyses of gene clusters. Inversions are resistant to homologous
recombination events (Silver, 1993) and could therefore be used to ﬁx alleles, in a manner
analogoustotheT-complex.
Although oV-target mutations were reported to be high in some cancer cell lines
manipulated by CRISPR system (Fu et al., 2013; Hsu et al., 2013) recent reports showed
that oV–target mutations in pluripotent cells and knockout mice are rare. In addition,
two or more interspaced mismatches dramatically reduce Cas9 cleavage (Yang et al.,
2013). Another recent report showed that guide-RNA:Cas9 speciﬁcity extends past
a 7- to 12-base-pair seed sequence. This suggests oV-target mutations could be low
(Pattanayaketal.,2013).
In summary, the combination of the CRISPR RNA-guided Cas9 nuclease system and
haploid ESCs allows eYcient genetic manipulation of the mammalian genome; this
technique provides a new tool for genetic analyses of complex biological phenomena
anddiseases.
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